Mundy J - Search Results

1

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.

Hawkins RE, Roberts K, Wiltshaw E, Mundy J, McCready VR. Hawkins RE, et al. Among authors: mundy j. Br J Cancer. 1989 Oct;60(4):634-7. doi: 10.1038/bjc.1989.329. Br J Cancer. 1989. PMID: 2803938 Free PMC article.

2

The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma.

Hawkins RE, Roberts K, Wiltshaw E, Mundy J, Fryatt IJ, McCready VR. Hawkins RE, et al. Among authors: mundy j. Br J Obstet Gynaecol. 1989 Dec;96(12):1395-9. doi: 10.1111/j.1471-0528.1989.tb06301.x. Br J Obstet Gynaecol. 1989. PMID: 2620051

3

62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases.

Flower MA, Zweit J, Hall AD, Burke D, Davies MM, Dworkin MJ, Young HE, Mundy J, Ott RJ, McCready VR, Carnochan P, Allen-Mersh TG. Flower MA, et al. Among authors: mundy j. Eur J Nucl Med. 2001 Jan;28(1):99-103. doi: 10.1007/s002590000410. Eur J Nucl Med. 2001. PMID: 11202458 Clinical Trial.

4

Thyroglobulin antibodies in differentiated thyroid cancer.

Hjiyiannakis P, Mundy J, Harmer C. Hjiyiannakis P, et al. Among authors: mundy j. Clin Oncol (R Coll Radiol). 1999;11(4):240-4. doi: 10.1053/clon.1999.9056. Clin Oncol (R Coll Radiol). 1999. PMID: 10473720

5

Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.

Selby PJ, Lopes N, Mundy J, Crofts M, Millar JL, McElwain TJ. Selby PJ, et al. Among authors: mundy j. Br J Cancer. 1987 May;55(5):531-3. doi: 10.1038/bjc.1987.108. Br J Cancer. 1987. PMID: 3111515 Free PMC article.

6

Tumour incidence and tumour-free sublines in BR6 mice.

MUNDY J, WILLIAMS PC. MUNDY J, et al. Br J Cancer. 1961 Sep;15(3):561-7. doi: 10.1038/bjc.1961.65. Br J Cancer. 1961. PMID: 14477198 Free PMC article. No abstract available.

7

Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug scheduling.

Mansi J, Ellis E, Viner C, Mundy J, Smith T, Millar J, Milan S, Gore M, Cunningham D. Mansi J, et al. Among authors: mundy j. Cancer Chemother Pharmacol. 1992;30(2):149-51. doi: 10.1007/BF00686408. Cancer Chemother Pharmacol. 1992. PMID: 1600595 Clinical Trial.

8

51Cr-EDTA test for intestinal permeability.

Selby P, McElwain TJ, Crofts M, Lopes N, Mundy J. Selby P, et al. Among authors: mundy j. Lancet. 1984 Jul 7;2(8393):38-9. doi: 10.1016/s0140-6736(84)92018-x. Lancet. 1984. PMID: 6145950 No abstract available.

9

Transmissible agent associated with some mouse neoplasms.

MUNDY J, WILLIAMS PC. MUNDY J, et al. Science. 1961 Sep 22;134(3482):834-5. doi: 10.1126/science.134.3482.834. Science. 1961. PMID: 13726802

10

KorB switching from DNA-sliding clamp to repressor mediates long-range gene silencing in a multi-drug resistance plasmid.

McLean TC, Balaguer-Pérez F, Chandanani J, Thomas CM, Aicart-Ramos C, Burick S, Olinares PDB, Gobbato G, Mundy JEA, Chait BT, Lawson DM, Darst SA, Campbell EA, Moreno-Herrero F, Le TBK. McLean TC, et al. Among authors: mundy jea. Nat Microbiol. 2025 Jan 23. doi: 10.1038/s41564-024-01915-3. Online ahead of print. Nat Microbiol. 2025. PMID: 39849085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters